Phenacetin came into use in 1887, just 10 years after the first case of renal papillary necrosis was reportedl 2 but the association between the excessive use of phenacetin-containing analgesics and the development of renal damage was not recognised until 1953,3 since when there has been gradual recognition that excessive analgesic consumption is a major cause of chronic renal disease in many parts of the world.
The initial emphasis on phenacetin has given way to the realisation that many analgesic mixtures are nephrotoxic. Such mixtures are readily available to the public and are widely advertised, not just for pain relief, but as tonics and general panaceas. Despite restrictions on the sale of phenacetin and its major metabolite paracetamol in several countries, abuse of analgesic mixtures has continued and there is no definite evidence that the incidence of analgesic nephropathy is declining.
Renal damage in analgesic nephropathy is due to a combination of renal papillary necrosis and chronic interstitial nephritis. In many cases the disease runs a rapidly progressive course with death from renal failure within a few years of the initial presentation. This paper is based on a study carried out in Nottingham, and outlines the major features of analgesic nephropathy in the United Kingdom. The clinical features of analgesic nephropathy are now widely recognised yet many patients have already developed severe renal failure by the time the history of analgesic abuse is obtained.4 5 Unless the association with a high analgesic consumption is recognised, the renal damage is often attributed to bacterial infection and the condition labelled "pyelonephritis." Several studies have shown, however, that bacterial urinary tract infection in the adult rarely leads to end-stage renal failure,5 6 and Heptinstall has emphasised that the small, scarred kidney often labelled "chronic pyelonephritis" is the end result of many different pathological processes; in many cases the original disease cannot be determined. 7 Early diagnosis of analgesic nephropathy is important since complete withdrawal of analgesics before significant renal damage has occurred will result in improvement in renal function. As part of the survey 20 229 necropsy reports were examined for the presence of renal disease. The necropsy rate in the Nottingham hospitals was 65 %, which is higher than that reported in many other series.13 14 Nevertheless the survey probably underestimated the true incidence of papillary necrosis, for in only about half of the necropsy reports was there evidence that the papillae had been examined. There are a number of features which should make Analgesic nephropathy in the United Kingdom: incidence, clinical features andpathogenesis Table 4 ). Clinical examination is often unhelpful. Anaemia may be more severe than expected from the degree of renal failure; this has been attributed to chronic gastrointestinal bleeding due to a high salicylate intake. Hypertension is uncommon and proteinuria is moderate or absent in the early stages.
Examination of the urine typically reveals numerous leucocytes with or without bacterial infection. A persistent sterile pyuria should alert the clinician to the possibility of analgesic nephropathy, but many patients also suffer from recurrent urinary tract infections. Occasionally the passage of debris may indicate shedding of a papilla; in this case the urine should be strained and any tissue sent for histological examination.
Haematuria may indicate active papillary necrosis, but can also herald the development of a transitional carcinoma of the renal pelvis, which occurs in about 10% of cases of analgesic nephropathy.30 Regular cytological examination of the urine may help in the early detection of these tumours.31
A very useful technique both for diagnosis and for following patients with analgesic nephropathy is to examine a sample of urine for salicylates and paracetamol: one method involves saturating the urine sample with salt, after which the urine is extracted with ether and scanned under ultraviolet light.32 "Phenistix" (Ames) can be used as a simple screening test and will detect salicylates in the urine for up to 48 hours after ingestion.33
Radiological appearances reflect the pathological changes. In the early stages intravenous urography may be normal. Typical x-ray changes of papillary necrosis are seen in only 20-30 % of cases. The commonest finding is reduction in size of both kidneys with irregularity of the outline due to shallow scars, which may often be misinterpreted as "chronic pyelonephritis."
Renal biopsy is generally unhelpful since it merely shows interstitial nephritis without indicating the cause. Lee et al.34 suggested that demonstration of a lipofuscin pigment in the tubules should arouse suspicion of analgesic abuse but this occurs in other conditions and an accurate drug history should already have alerted the clinician to the possibility of analgesic damage. The importance of making a distinction between analgesic nephropathy and chronic pyelonephritis has been emphasised by Gower.37 In a series of patients with radiological evidence of pyelonephritis he observed that deterioration in renal function occurred more rapidly in the group taking analgesics. Most of the patients with papillary necrosis in his series had a history of analgesic abuse and their survival rate was 56°, at 10 years, compared with 86", for those without papillary necrosis. In the Nottingham series the survival rate was only 440"O at 5 years, reflecting the poor renal function of most patients at presentation. The prognosis was especially poor if the serum creatinine found at the time of diagnosis was greater than 400 tumol/l, and the mortality rate could be related both to the degree of renal failure and the estimated total consumptioni of analgesics.
Pathogenesis of analgesic nephropathy
Burry refers to three stages of papillary necrosis *3'8 namely, early, intermediate and total.
In the early stage only the papillary tip appears to be affected, with yellow coloration and some pale streaking of the pyramid; the cortex is normal.
In the intermediate stage the papillae are intact but shrunken and pale with radial streaks marking the upper zone of degeneration. The cortex is often coarsely scarred but of normal thickness.
The group with total necrosis shows a range of changes. In the most severely affected kidneys the cortical surface is slightly irregular with raised areas corresponding to the "renal columns". The It is now accepted that in the majority of cases analgesic nephropathy results from the excessive consumption of analgesic mixtures, usually containing aspirin with either phenacetin or paracetamol. The synergism between aspirin and phenacetin may be the result of some complex metabolic interaction, but it seems likely that the inhibition of prostaglandin synthetase in the renal medulla by aspirin causes relative ischaemia and that, particularly in the presence of dehydration, toxic metabolites of phenacetin, which probably include paracetamol, are concentrated in the renal papilla and damage the ischaemic tissue.
Phenacetin has recently been replaced by paracetamol in many analgesic mixtures available "overthe-counter." It is too early to say whether this will lead to a reduction in the incidence of analgesic nephropathy.
In summary, analgesic abuse remains an important cause of renal damage which is still commonly missed. The diagnosis depends on a high index of suspicion and a careful search for the features of analgesic nephropathy. Early diagnosis is important since cessation of analgesic intake may result in improvement in renal function. 
